Drug Profile
Tadalafil orodispersible film tablet - Abbott Healthcare Products
Alternative Names: CaliberiLatest Information Update: 01 Jan 2022
Price :
$50
*
At a glance
- Originator Abbott Healthcare Products
- Class Antihypertensives; Benzodioxoles; Carbolines; Erectile dysfunction therapies; Gastrokinetics; Heart failure therapies; Indoles; Ischaemic heart disorder therapies; Pyridones; Small molecules; Vascular disorder therapies; Vasodilators
- Mechanism of Action Type 5 cyclic nucleotide phosphodiesterase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Erectile dysfunction
Most Recent Events
- 28 Feb 2020 No recent reports of development identified for phase-I development in Erectile-dysfunction(In volunteers) in Thailand (PO, Tablet)
- 06 Nov 2018 Abbott Healthcare Products completes a phase I trial in Erectile dysfunction (In volunteers) in Thailand (PO) (TCTR20161031001)
- 20 Jul 2017 Chemical structure information added